Capecitabine/ irinotecan (CapIri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with advanced colorectal cancer (ACRC) after failure of first-line combination therapy: Results of a randomized phase II study

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3534-3534 ◽  
Author(s):  
A. Grothey ◽  
K. Jordan ◽  
O. Kellner ◽  
C. Constantin ◽  
G. Dietrich ◽  
...  
2005 ◽  
Vol 16 (6) ◽  
pp. 869-877 ◽  
Author(s):  
H.P. Kalofonos ◽  
G. Aravantinos ◽  
P. Kosmidis ◽  
P. Papakostas ◽  
T. Economopoulos ◽  
...  

2005 ◽  
Vol 16 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Ralf-Dieter Hofheinz ◽  
Ulrike Gnad-Vogt ◽  
Axel Wein ◽  
Susanne Saussele ◽  
Sebastian Kreil ◽  
...  

2012 ◽  
Vol 14 (8) ◽  
pp. 606-612 ◽  
Author(s):  
Cristina Gravalos ◽  
Antonieta Salut ◽  
Carlos García-Girón ◽  
Rocío García-Carbonero ◽  
Ana Isabel León ◽  
...  

2010 ◽  
Vol 66 (5) ◽  
pp. 987-992 ◽  
Author(s):  
Manabu Shiozawa ◽  
Makoto Akaike ◽  
Nobuhiro Sugano ◽  
Kazuhito Tsuchida ◽  
Naoto Yamamoto ◽  
...  

2003 ◽  
Vol 52 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Tadamichi Denda ◽  
Tomonori Ambo ◽  
Atsushi Ohtsu ◽  
Yasuhide Yamada ◽  
Kuniaki Shirao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document